Home » Topics » Regulatory

Regulatory
RSS

Eisai launches new formulation of rufinamide in U.K.

April 16, 2012

European Commission approves Humira for new indication

April 12, 2012

Korlym now available in U.S.

April 11, 2012

FDA approves adjunct radioactive diagnostic for Alzheimer's disease

April 10, 2012

New product approved for T-cell leukemia-lymphoma

March 30, 2012

Kiklin capsules approved in Japan

March 30, 2012

FDA approves line extension for etravirine

March 29, 2012

Affymax and Takeda receive first approval for Omontys

March 28, 2012

Line extension for Taxol approved in Japan

March 22, 2012

Flagyl approved for additional indication in Japan

March 22, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...